Įmonių pranešimai · 2026-11-131 min read
Leqembi® Pen subcutaneous treatment launched in Japan
Vietinis automatinis vertimas · Pradinis šaltinio kalba
Summary
STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…
Pradinis šaltinio kalba: PR Newswire UK — News ReleasesAtidaryti pirminį pranešimą →